ETS1 is a transcription factor capable of binding to purine rich core motif (-GGAA-) present in the promoter/enhancer regions of many cellular and viral genes. ETS1 is expressed at high levels in lymphoid cells. Blocking the formation of ETS1 in Jurkat T-cells increases their ability to produce Interleukin-2. To elucidate the role of ETS1 in T-cells, we have expressed mutant forms of ETS1 in Jurkat T-cells and obtained several stable cell lines. Jurkat T-cells expressing ETS1 DNA binding domain (lacking transcriptional activities) remain at G0/G1 stage for a longer time and upon activation, produce lower amounts of lymphokines. Experiments are in progress to identify the cellular target genes for ETS1. ERGB/FLi1 is a member of the ets family of transcription factors. ERGB/FLi1 gene expression is higher in peripheral blood mononuclear cells from lupus patients than from healthy individuals. Its expression correlates with the aggressiveness of the disease. ErgB/Fli1 but not Ets1 gene expression is higher in splenic T-cells from autoimmune-prone mice than from normal mice. ErgB/Fli1 gene expression is also high in salivary glands from human T-cell leukemia virus Tax1 transgenic mice than the normal mice. Experiments are in progress to find out if ErgB/Fli1 could be used as a marker for autoimmune disease and to understand its role in T-cell proliferation and activation processes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01CP005443-11
Application #
5201491
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Division of Cancer Epidemiology and Genetics
Department
Type
DUNS #
City
State
Country
United States
Zip Code